We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$25.3B
AUM Growth
+$814M
Cap. Flow
+$613M
Cap. Flow %
2.42%
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.9M
2
AAPL icon
Apple
AAPL
+$24.9M
3
T icon
AT&T
T
+$21.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.2M
5
BIIB icon
Biogen
BIIB
+$19.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$34M
2
RHT
Red Hat Inc
RHT
+$22.2M
3
HSBC icon
HSBC
HSBC
+$20.3M
4
APC
Anadarko Petroleum
APC
+$19.9M
5
CAJ
Canon, Inc.
CAJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 16.76%
3 Healthcare 12.56%
4 Consumer Discretionary 10.05%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRGI
2851
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
-9,916
Closed -$130K
HCCI
2852
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
-1,650
Closed -$43K
RETA
2853
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-2,316
Closed -$219K
INFI
2854
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-994
Closed -$2K
FRBK
2855
DELISTED
Republic First Bancorp Inc
FRBK
-2,808
Closed -$14K
ACGN
2856
DELISTED
Aceragen Inc
ACGN
-66
Closed -$3K
KDNY
2857
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-189
Closed -$1K
NOVN
2858
DELISTED
Novan, Inc. Common Stock
NOVN
-182
Closed -$5K
TESS
2859
DELISTED
Tessco Technologies Inc
TESS
-71
Closed -$1K
ISEE
2860
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-161
Closed
IMBI
2861
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
-305
Closed -$1K
USX
2862
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
-125
Closed -$1K
BLCM
2863
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-204
Closed -$3K
MGI
2864
DELISTED
MoneyGram International, Inc. New
MGI
-8,614
Closed -$21K
VNTR
2865
DELISTED
Venator Materials PLC
VNTR
-14,686
Closed -$78K
MAXR
2866
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-14,741
Closed -$115K
LMST
2867
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
-1,525
Closed -$23K
CIH
2868
DELISTED
China Index Holdings Limited American Depository Shares
CIH
-2,232
Closed -$8K
DTEA
2869
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
-1,181
Closed -$2K
PLXP
2870
DELISTED
PLx Pharma Inc. Common Stock
PLXP
-1,851
Closed -$13K
AGFS
2871
DELISTED
AgroFresh Solutions Inc
AGFS
-340
Closed -$1K
SIOX
2872
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-366
Closed -$2K
AMOV
2873
DELISTED
America Movil SAB de CV
AMOV
-226
Closed -$3K
MYOV
2874
DELISTED
Myovant Sciences Ltd.
MYOV
-1,219
Closed -$11K
FCRD
2875
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
-624
Closed -$4K

Similar funds

Aperio Group's Q3 2019 Portfolio in Review

As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
  • Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
  • Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
  • Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
  • Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
  • Aperio Group opened 5 new positions and closed 769 in Q3 2019.
  • Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.